Zurcher Kantonalbank (Zurich Cantonalbank) Relay Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $30.1 Billion
- Q2 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 21,514 shares of RLAY stock, worth $140,701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,514
Previous 21,514
-0.0%
Holding current value
$140,701
Previous $178,000
21.35%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RLAY
# of Institutions
183Shares Held
127MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$55.3 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.7 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $786M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...